Rivaroxaban

Founded in 1992 and headquartered in Chongqing, Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. manufactures prophylactic biological products and has expanded steadily since a new R&D center opened in 2006 and its Huapont Shengchem production site came online in 2007, followed by a new dosage facility in 2008. In 2012 the company obtained New Zealand GMP certification and passed a US FDA audit, and it now sells across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa, drawing on an experienced R&D staff, solid production capacity, and a reputation for quality service and accommodating buyer specifications.